Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2006
12/05/2006US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents
12/05/2006US7144892 Treatment of cardiovascular and related pathologies
12/05/2006US7144891 derivatives of acronycine such as cis-2-cinnamoyloxy-1-hydroxy-6-methoxy-3,3,14-trimethyl-1,2,3,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridin-7-one, used as antitumor agents
12/05/2006US7144885 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
12/05/2006US7144691 Oxiranylmethoxyhydrocarbyl-N-oxypiperidine derivatives as stabilizers; blue sensitive silver halide emulsion layer yellow coupler, green sensitive layer contains magenta coupler, and red sensitive layer contains cyan coupler; storage stability
12/05/2006CA2176604C Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin
12/05/2006CA2150382C Process for the preparation of 9-amino camptothecin
11/2006
11/30/2006WO2006125974A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
11/30/2006WO2006125812A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
11/30/2006WO2006125805A1 Thiazole derivatives and use thereof
11/30/2006US20060270729 Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
11/30/2006US20060270728 Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/30/2006US20060270689 Novel Fused Heterocycles and Uses Thereof
11/30/2006US20060270672 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
11/30/2006US20060270656 Substituted piperazines of azepines, oxazepines and thiazepines
11/30/2006US20060269622 Formulations and methods of administration of cephalotaxines, including homoharringtonine
11/30/2006CA2609392A1 Modulators of atp-binding cassette transporters
11/30/2006CA2608072A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
11/30/2006CA2607385A1 Thiazole derivatives and their use for the treatment and/or prophylaxis of disorders and diseases
11/30/2006CA2604165A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
11/29/2006EP1726592A1 Dioxino derivatives and their use as dopanine agonists
11/29/2006EP1726590A1 Cycloalkanopyridine derivative
11/29/2006EP1726585A1 Diaryl-substituted five-membered heterocycle derivative
11/29/2006EP1725567A1 Spirocyclic cyclohexane derivatives with affinity to the orl-1 receptor
11/29/2006EP1725239A1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
11/29/2006EP1628982A4 Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin
11/29/2006EP0971854B1 Novel materials useful as electrolytic solutes
11/29/2006CN1871241A Spirofuropyridine aryl derivatives
11/29/2006CN1871233A Novel chelating agents and chelates and their use
11/29/2006CN1870896A Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
11/29/2006CN1287369C Optical data carrier whose information layer contains light-absorbing compound having a number of chromophoric centers
11/29/2006CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006CN1286809C Arylphenyl-substituted cyclic ketoenols compound
11/28/2006US7141583 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/28/2006US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006US7141578 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile
11/28/2006US7141574 Viral polymerase inhibitors
11/28/2006US7141567 such as (7R,8R,9R)-8-hydroxy-2-methyl-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine; for treatment of gastrointestinal disorders
11/28/2006US7141565 Substituted quinobenzoxazine analogs
11/28/2006US7141564 are active against a wide range of organisms including both Gram-negative and Gram-positive organisms
11/28/2006US7141561 Substituted diaryl heterocycles, process for their preparation and their use as medicaments
11/28/2006CA2305370C Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
11/28/2006CA2215518C Process for preparing galanthamine derivatives by asymmetric reduction
11/28/2006CA2137203C Protein kinase c inhibitors
11/28/2006CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006WO2006124490A2 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
11/23/2006WO2006123242A1 1, 2, 4 -triazole derivatives as vasopressin antagonists
11/23/2006WO2006089633A3 Spiroketal-substituted cyclic ketoenols
11/23/2006WO2006078865A3 Direct racemization of indole derivatives
11/23/2006WO2005054234A8 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
11/23/2006WO2004103272A3 Improved cytotoxic agents comprising new maytansinoids
11/23/2006US20060264459 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
11/23/2006US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006US20060264452 Analgesics; immunomodulators and for treatment of drug dependence; for example, 5'-Bromo-17-(cyclopropylmethyl)-6,7-didehydro-3,14-dihydroxy-4,5 alpha -epoxypyrido[2',3':6,7]morphinan
11/23/2006US20060264449 Compounds for modulation of kinesins as anticancer agents with administering
11/23/2006US20060264437 Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-F]quinoline as 5-HT1A antagonists
11/23/2006US20060264428 Tri-, tetra-substituted-3-aminopyrrolidine derivative
11/23/2006US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006US20060264419 Substituted pyrazoles
11/23/2006US20060264416 Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
11/23/2006DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006CA2608718A1 1, 2, 4-triazole derivatives as vasopressin antagonists
11/23/2006CA2608405A1 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
11/22/2006EP1724267A1 Pyrimidine derivative
11/22/2006EP1723956A1 Preventive or therapeutic agents for severe diabetic retinopathy
11/22/2006EP1723208A1 Reversible piezochromic systems
11/22/2006EP1723150A1 Rifamycin imino derivatives effective against drug-resistant microbes
11/22/2006EP1723134A2 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
11/22/2006EP1722793A1 Bicyclic modulators of androgen receptor function
11/22/2006EP1722779A1 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents
11/22/2006EP1554243B1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
11/22/2006EP1540382A4 Plastic photochromic lens and method for preparation thereof
11/22/2006EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006CN1867566A Aminopyrones and their use as ATM inhibitors
11/22/2006CN1867562A Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
11/22/2006CN1865219A 2- and 2,5-substituted phenylketo-enols
11/22/2006CN1285597C 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
11/21/2006US7138522 Rylene derivatives and their use as dyes
11/21/2006US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006US7138397 Nitrogenous 5-membered ring compounds
11/21/2006CA2168022C Vasoconstrictive substituted dihydropyranopyridines
11/16/2006WO2006121106A1 Method for producing indole derivative having piperidine ring
11/16/2006WO2006120478A2 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/16/2006US20060258737 Resistance-repellent retroviral protease inhibitors
11/16/2006US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006US20060258652 Beta-blockers having antioxidant and no-donor activity
11/16/2006US20060258648 9-Azabicyclo'3.3.1 inon-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors
11/16/2006US20060258646 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/16/2006US20060258637 Fused polycyclic compounds
11/16/2006CA2607874A1 Quinoline derivatives as neurokinin receptor antagonists
11/15/2006EP1721522A2 Substituted phenylketo-enoles as biocides and herbicides
11/15/2006EP1720891A1 Crystalline forms of a pharmaceutical compound
11/15/2006EP1720839A1 Pyridazinones as antagonists of a4 integrins
11/15/2006EP1720613A2 Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogernase 3
11/15/2006EP1720542A1 Arylalkylamino-substituted quinazoline analogues
11/15/2006EP1411881B9 5ht2c receptor modulators
11/15/2006CN1863835A Process for making amide acetals